SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:uu-213306"
 

Search: id:"swepub:oai:DiVA.org:uu-213306" > Renal Effects of Le...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Renal Effects of Levosimendan : A Consensus Report

Yilmaz, Mehmet B. (author)
Grossini, Elena (author)
Silva Cardoso, Jose C. (author)
show more...
Edes, Istvan (author)
Fedele, Francesco (author)
Pollesello, Piero (author)
Kivikko, Matti (author)
Harjola, Veli-Pekka (author)
Hasslacher, Julia (author)
Mebazaa, Alexandre (author)
Morelli, Andrea (author)
le Noble, Jos (author)
Oldner, Anders (author)
Karolinska Institutet
Oulego Erroz, Ignacio (author)
Parissis, John T. (author)
Parkhomenko, Alexander (author)
Poelzl, Gerhard (author)
Rehberg, Sebastian (author)
Ricksten, Sven-Erik, 1953 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård,Institute of Clinical Sciences, Department of Anesthesiology and Intensive care
Rodriguez Fernandez, Luis M. (author)
Salmenpera, Markku (author)
Singer, Mervyn (author)
Treskatsch, Sascha (author)
Vrtovec, Bojan (author)
Wikström, Gerhard (author)
Uppsala universitet,Kardiologi
show less...
 (creator_code:org_t)
2013-08-09
2013
English.
In: Cardiovascular Drugs and Therapy. - : Springer Science and Business Media LLC. - 0920-3206 .- 1573-7241. ; 27:6, s. 581-590
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Renal dysfunction is common in clinical settings in which cardiac function is compromised such as heart failure, cardiac surgery or sepsis, and is associated with high morbidity and mortality. Levosimendan is a calcium sensitizer and potassium channel opener used in the treatment of acute heart failure. This review describes the effects of the inodilator levosimendan on renal function. A panel of 25 scientists and clinicians from 15 European countries (Austria, Finland, France, Hungary, Germany, Greece, Italy, Portugal, the Netherlands, Slovenia, Spain, Sweden, Turkey, the United Kingdom, and Ukraine) convened and reached a consensus on the current interpretation of the renal effects of levosimendan described both in non-clinical research and in clinical study reports. Most reports on the effect of levosimendan indicate an improvement of renal function in heart failure, sepsis and cardiac surgery settings. However, caution should be applied as study designs differed from randomized, controlled studies to uncontrolled ones. Importantly, in the largest HF study (REVIVE I and II) no significant changes in the renal function were detected. As it regards the mechanism of action, the opening of mitochondrial K-ATP channels by levosimendan is involved through a preconditioning effect. There is a strong rationale for randomized controlled trials seeking beneficial renal effects of levosimendan. As an example, a study is shortly to commence to assess the role of levosimendan for the prevention of acute organ dysfunction in sepsis (LeoPARDS).

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Anestesi och intensivvård (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Anesthesiology and Intensive Care (hsv//eng)

Keyword

Levosimendan
Renal dysfunction

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view